Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery

This publication has 16 references indexed in Scilit:

• In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates
  Journal of Antimicrobial Chemotherapy, 1997
• In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin
  European Journal of Clinical Microbiology & Infectious Diseases, 1996
• EFFICACY OF TROVAFLOXACIN (CP-99,219), A NEW FLUOROQUINOLONE, IN AN ANIMAL MODEL OF INTRAABDOMINAL SEPSIS
  Infectious Diseases in Clinical Practice, 1996
• Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci
  Journal of Antimicrobial Chemotherapy, 1996
• In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis
  Antimicrobial Agents and Chemotherapy, 1995
• Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteers
  Journal of Antimicrobial Chemotherapy, 1995
• In vitro activity of the new fluoroquinolone CP-99,219
  Antimicrobial Agents and Chemotherapy, 1994
• Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes
  Antimicrobial Agents and Chemotherapy, 1994
• In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria
  Antimicrobial Agents and Chemotherapy, 1993
• In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone
  Antimicrobial Agents and Chemotherapy, 1993